๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Prostate Cancer
Clinical trial register · China

Prostate Cancer Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 12 Shenzhen 1 Baoding 1
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing12 Shenzhen1 Baoding1
All 3 locations
Target enrolment
to

Prostate Cancer trials in China

12 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
Clinically Actionable Tumor-Associated Antigens in Prostate Cancer
NCT07597369Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Cancer (mCRPC)
Peking University First Hospital
Observational
1,600
Beijing
2026-01-01
Not yet open
Darolutamide+ADT Post-RP w/o ePLND in hrPC: Briganti 2019
NCT07282197Prostate Cancer
Peking University First Hospital
Phase 2
40
Beijing
2026-01
Not yet open
Enhanced Recovery After Surgery (ERAS) Pathway in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy
NCT05576766Prostate Cancer, Robot-Assisted Laparoscopic Radical Prostatectomy, Enhanced Recovery After Surgery (ERAS) Protocol, Prehabilitation
Peking University First Hospital
Not applicable
54
Beijing
2025-09
Recruiting
Comprehensive Versus Primary Tumor Radiotherapy in Oligometastatic Prostate Cancer
NCT07015138Prostate Cancer, Oligometastatic Prostate Cancer
Peking University First Hospital
Not applicable
390
Beijing
2025-06-01
Active, closed
The Value of Dual-parametric Magnetic Resonance Combined With Regional Saturation Biopsy in Patients With Suspected Prostate Cancer
NCT06824259Prostate Cancer
Peking University First Hospital
Not applicable
400
Beijing
2025-05-14
Recruiting
Optimizing Prostate Biopsy Schemes in Men With Multiple MRI Visible Lesions
NCT06841211Prostate Cancer
Peking University First Hospital
Not applicable
572
Beijing
2025-02-01
Recruiting
Evaluation of Targeted Biopsy Plus Sextant Biopsy in Diagnosis of Prostate Cancer
NCT06684652Prostate Cancer
Peking University First Hospital
Not applicable
300
Beijing
2024-12-01
Recruiting
Evaluation of Perilesional Biopsy in Diagnosis of Prostate Cancer
NCT06482645Prostate Cancer
Peking University First Hospital
Not applicable
640
Beijing
2024-07-01
Recruiting
Comparison of MRI Artificial Intelligence-guided cTB Versus Routine cTB in Prostate Cancer Diagnosis
NCT06392737Prostate Cancer
Peking University First Hospital
Not applicable
360
Beijing
2024-05-01
Recruiting
Establishment and Promotion of an AI-Based Early Warning System for Prostate and Bladder Cancer Screening in the Male Community Population of Beijing
NCT07319923Prostate Cancer, Community-based Screening
Peking University First Hospital
Observational
3,000
Beijing
2024-01-01
Recruiting
The Development and Validation of MRI-AI-based Predictive Models for csPCa
NCT06842264Prostate Cancer
Peking University First Hospital
Observational
3,000
Beijing
2024-01-01
Recruiting
Adjuvant Chemotherapy for High Malignant Prostate Cancer
NCT06864533Prostate Cancer, Radiation Therapy, Chemotherapy, Gleason Score
Peking University First Hospital
Observational
315
Beijing, Shenzhen, Baoding
2019-09-01
Rows per page Showing 1–12 of 12
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 September 2026. https://priyalifescience.com/clinical-trials-china/condition/prostate-cancer

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 12 of those studies listing the condition Prostate Cancer that also match the filters currently applied.

How many Prostate Cancer trials are recruiting in China?

8 of the 12 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 2 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Prostate Cancer), 12 studies
PhaseStudiesRecruitingShare
Not applicable7558.3%
Observational4333.3%
Phase 2108.3%

Most active sponsors

Lead sponsors with the most studies (Prostate Cancer)
Lead sponsorStudiesRecruiting
Peking University First Hospital128
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.